300636 Stock Overview
Jiangxi Synergy Pharmaceutical Co., Ltd. produziert und vertreibt weltweit Wirkstoffe.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Jiangxi Synergy Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.64 |
| 52 Week High | CN¥14.13 |
| 52 Week Low | CN¥5.76 |
| Beta | -0.0080 |
| 1 Month Change | 4.23% |
| 3 Month Change | -24.95% |
| 1 Year Change | -43.28% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -47.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300636 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.7% | 0.7% | 0.9% |
| 1Y | -43.3% | -14.7% | -16.5% |
Rendite im Vergleich zur Industrie: 300636 unter dem Niveau der Branche CN Pharmaceuticals , die im vergangenen Jahr eine Rendite von -14% erzielte.
Rendite vs. Markt: 300636 hinter dem Markt CN zurück, der im vergangenen Jahr eine Rendite von -14.9 erzielte.
Price Volatility
| 300636 volatility | |
|---|---|
| 300636 Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 11.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stabiler Aktienkurs: 300636Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: 300636Die wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,280 | Zhengwei Pang | https://www.jxsynergy.com |
Jiangxi Synergy Pharmaceutical Co., Ltd. produziert und vertreibt weltweit APIs. Das Unternehmen bietet Rohmaterialien, pharmazeutische Zwischenprodukte und Feinchemikalien an. Jiangxi Synergy Pharmaceutical Co., Ltd.
Jiangxi Synergy Pharmaceutical Co., Ltd. Fundamentals Summary
| 300636 fundamental statistics | |
|---|---|
| Market cap | CN¥3.21b |
| Earnings (TTM) | CN¥104.83m |
| Revenue (TTM) | CN¥751.30m |
30.6x
P/E Ratio4.3x
P/S RatioIs 300636 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300636 income statement (TTM) | |
|---|---|
| Revenue | CN¥751.30m |
| Cost of Revenue | CN¥504.99m |
| Gross Profit | CN¥246.31m |
| Other Expenses | CN¥141.48m |
| Earnings | CN¥104.83m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 0.25 |
| Gross Margin | 32.78% |
| Net Profit Margin | 13.95% |
| Debt/Equity Ratio | 32.5% |
How did 300636 perform over the long term?
See historical performance and comparison